Jacobs Receives Contract from Pfizer.PASADENA, Calif. -- Jacobs Engineering Group Jacobs Engineering Group Inc. (NYSE: JEC), a publicly traded company with annual revenues approaching $7 billion, provides professional technical services. Headquartered in Pasadena, CA, Jacobs offers support to industrial, commercial, and government clients across multiple Inc. (NYSE NYSE See: New York Stock Exchange :JEC) announced today that a subsidiary company received a contract from Pfizer to provide preliminary engineering services for Pfizer's Focus Freeze Dry project in Puurs, Belgium. Officials did not disclose the contract value. This project expands the current aseptic aseptic /asep·tic/ (-tik) free from infection or septic material. a·sep·tic adj. Of, relating to, or characterized by asepsis. production facilities with a new formulation area, additional filling and freeze dry capacity, and required auxiliary operations. In making the announcement, Jacobs Group Vice President Andy Kremer stated, "We are very pleased that Pfizer selected us for a third consecutive freeze dry expansion project at this site. The Puurs project is a significant extension of our relationship with Pfizer in Europe and we look forward to working with them to achieve their objectives for this important project." Jacobs, with over 35,000 employees and revenues approaching $5.0 billion, provides technical, professional, and construction services globally. Any statements made in this release that are not based on historical fact are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . Any forward-looking statements made in this release represent management's best judgement as to what may occur in the future. However, Jacobs' actual outcome and results are not guaranteed and are subject to certain risks, uncertainties and assumptions ("Future Factors"), and may differ materially from what is expressed. For a description of Future Factors that could cause actual results to differ materially from such forward-looking statements, see the discussion under the section "Forward-Looking Statements" included in Item 7 -- Management's Discussion and Analysis Management's discussion and analysis (MD&A) A report from management to shareholders that accompanies the firm's financial statements in the annual report. It explains the period's financial results and enables management to discuss topics that may not be apparent in the financial of Financial Condition and Results of Operations contained in the Company's 2004 Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. . |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion